Skip to main content

Donors Advisory Committee

The Donors Advisory Committee (DAC) advises DCVMN on donor-funded activities and has no executive role. As a strictly advisory, non-governing body, the DAC does not have either decision-making authority or fiduciary responsibilities. It is composed by three DCVMN members and four external advisers from FVMRH/Imperial College London, PATH, BMGF and NIIMBL, who are supporting and guiding the Network on principles, technical and scientific activities for member manufacturers, e.g. training programs. Members are appointed by the Executive Committee according to advice and support requirements. DCVMN-CEO is the ex-officio member of DAC. Appointment duration is dependent on the Advisory Committee needs and individual availability.

Minutes to the formal virtual meetings are accessible to all members to consult by clicking here.



Tiago Rocca, BD


Mr. Rocca has been working at Butantan for over 15 years and has assumed responsibilities in vaccines and biopharmaceuticals production, technology transfer, validation and QA. He is a pharmacist and post-graduated in Health Law at Public Health School USP and in Pharma Business Management at ESPM. Currently is the Secretary of Emerging Biopharmaceuticals Manufacturers Network (EBPMN).


Adriansjah Azhari


Adriansjah is a member of the Board of Executives of Bio Farma as Senior Executive Vice President (SEVP) overseeing Research and Development activities. He has been in Bio Farma for more than 30 years with experience in bioprocessing, Quality Management and technology transfer. He has actively participated in interacting with global organizations for the company such as The Bill and Melinda Gates Foundation, PATH, CEPI and IVI on several projects. He is a pharmacist and holds a Master’s degree in Operations Management. Adriansjah was elected as president of DCVMN for the period of 2023 – 2025.


Jong Ho Park


Mr. Jongho Park is Director of the Overseas Sales Department in LG Chem. He joined the business support team of LG Chem in 1995. After 10 years of experience in developing and implementing a sales force effectiveness program for the domestic market, he moved to the overseas business team, becoming team leader in 2011. He then moved to the vaccine sales team as team leader in 2016, specializing in vaccines. After the Vaccine Business Division merged with the Specialty Drug Business Division, and he was promoted to Director of the Overseas Sales Department, in 2019, responsible for the leadership and overall management of overseas sales for vaccines, fertility treatment drugs, diagnostics and veterinary products. Mr Park has a Bachelor’s degree from Sungkyunkwan University in Korea, majoring in Genetic Engineering.


Prof. Kelvin H. Lee


Kelvin H. Lee is Gore Professor of Chemical and Biomolecular Engineering at the University of Delaware and is Director of NIIMBL: the National Institute for Innovation in Manufacturing Biopharmaceuticals, one of 16 Manufacturing USA Institutes. He received a BSE in Chemical Engineering from Princeton and PhD in Chemical Engineering from Caltech. He spent several years in the Biotechnology Institute at the ETH in Zurich, Switzerland and also completed a postdoc in Caltech’s Biology Division.


Ray Prasad


Mr. Prasad is Senior CMC Advisor in Vaccine Development, Global Health. Before joining The Foundation, Mr. Prasad was COO and President, Vaccines & Biologics at Biological E and a board member for Qualivax, a GSK-BE joint venture. Mr. Prasad’s 40 years of experience include senior roles at Genentech, Chiron Novartis, Medimmune and Genzyme.

Jessica Milman


Jessica has more than 20 years of experience in global health, primarily focused on the development and introduction of vaccines for the most vulnerable children and communities around the world. Ms. Milman drove the conceptualization, launch, and implementation of CVIA, including creating a new organizational structure and operating model. Prior to joining PATH, Ms. Milman worked at the Bill & Melinda Gates Foundation as an Initiative lead on the malaria team. In this role, she established the strategic approach and led the foundation’s multi-million-dollar efforts to develop malaria vaccines.

Zeynep Kantur Ozenci


Zeynep Kantur Ozenci is the Global Manager for Health and Education in the International Finance Corporation of the World Bank Group, leading the implementation of the Corporation’s strategy in health, life sciences, medtech and education sectors.

A Turkish national, Zeynep’s professional background blends a mix of policy work at the IBRD, leading investments and global sector initiatives in the IFC, and investment banking and corporate finance experience in the private sector. Among her flagship contributions, Zeynep has led efforts in creation of bankable structures for a major hospital PPP program in Turkey, marking the first time that IFC would finance large scale PPPs in the social sector. Most recently, she has played two key roles as the Global Upstream/Market Creation Lead for Health & Education sectors, and the Global Lead for IFC’s pandemic readiness and health resilience initiatives. As part of her responsibilities, Zeynep has led the development of the Global Health Platform and has been leading several of IFC’s pioneering activities under the platform, including the establishment of vaccine manufacturing capacities in low and middle income countries.


Prof. Robin Shattock


Professor Shattock is Head of Mucosal Infection and Immunity, Department of Medicine, Imperial College, London. His research focuses on the mechanisms of mucosal infection and the development of novel preventative strategies appropriate to a developing world setting. He oversees a portfolio of research that is supported by 26 members of staff and has published over 160 peer reviewed articles in this area.


Dr Benjamin Pierce


Dr. Pierce is Operations Manager for the Future Vaccine Manufacturing Research Hub, Imperial College London, directed by Prof Robin Shattock. The FVMR Hub is committed towards researching innovative and more cost-effective vaccines for populations in developing countries and includes 8 leading UK-based institutes as well as grantees laboratories in Vietnam), India, Uganda, China and Bangladesh. Dr Pierce holds a PhD in Chemistry from University of North Carolina.